Importancia del factor de crecimiento del endotelio vascular en la angiogénesis

Translated title of the contribution: The role of vascular endothelial growth factor in angiogenesis

Nicola Maruotti, Domenico Ribatti

Research output: Contribution to journalArticle

Abstract

Vascular endothelial growth factor (VEGF) is an important angiogenic factor. VEGF family includes VEGF-A, VEGF-B, VEGF-C, VEGF-D, VEGF-E and placental growth factor (PIGF) which by different interactions with three tyrosine kinase receptors, including VEGFR-1/Flt-1. VEGFR-2/Flk-1 and VEGFR-3/Flt-4, and two non protein tyrosine kinase receptors, including neuropilin-1 and -2, are responsible for endothelial cells proliferation, migration and expression of chemokines, cytokines and matrix metalloproteinases. VEGF, expressed in response to cytokines, growth factors, hormones, extracellular proteases, and hypoxia, has been detected in different tissues, such as brain, liver, spleen, kidney and skin, where it is produced by several cytotypes, including endothelial cells, fibroblasts, keratinocytes, macrophages, mast cells and tumor cells. VEGF is involved in several physiological and pathological conditions, including embryo development, vasculogenesis and early hematopoiesis, ovulation, wound repair, psoriasis, endometriosis, arteriosclerosis, diabetic retinophathy, neovascular age-related macular degeneration of the eye, chronic inflammatory diseases, and tumors. Since angiogenesis is a key event in tumor growth, invasion and metastasis. VEGF has been proposed as a therapeutic target in several tumor types, such as breast cancer, renal cell cancer, colorectal cancer and non small cells lung cancer. Furthermore, VEGF may be an interesting therapeutic agent in ischemic heart and peripheral diseases. Copyrigth

Original languageSpanish
Pages (from-to)383-386
Number of pages4
JournalSalud(i)Ciencia
Volume16
Issue number4
Publication statusPublished - Sep 2008

Fingerprint

Vascular Endothelial Growth Factor A
Vascular Endothelial Growth Factor Receptor-3
Receptor Protein-Tyrosine Kinases
Neoplasms
Intercellular Signaling Peptides and Proteins
Neuropilin-2
Vascular Endothelial Growth Factor B
Endothelial Cells
Vascular Endothelial Growth Factor D
Neuropilin-1
Cytokines
Vascular Endothelial Growth Factor C
Vascular Endothelial Growth Factor Receptor-1
Vascular Endothelial Growth Factor Receptor-2
Arteriosclerosis
Angiogenesis Inducing Agents
Hematopoiesis
Macular Degeneration
Endometriosis
Ovulation

Keywords

  • Angiogenesis
  • Antiangiogenesis
  • Endothelial cell
  • Tumor growth

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Importancia del factor de crecimiento del endotelio vascular en la angiogénesis. / Maruotti, Nicola; Ribatti, Domenico.

In: Salud(i)Ciencia, Vol. 16, No. 4, 09.2008, p. 383-386.

Research output: Contribution to journalArticle

Maruotti, N & Ribatti, D 2008, 'Importancia del factor de crecimiento del endotelio vascular en la angiogénesis', Salud(i)Ciencia, vol. 16, no. 4, pp. 383-386.
Maruotti, Nicola ; Ribatti, Domenico. / Importancia del factor de crecimiento del endotelio vascular en la angiogénesis. In: Salud(i)Ciencia. 2008 ; Vol. 16, No. 4. pp. 383-386.
@article{210f8d0715224e398961c81ede7920db,
title = "Importancia del factor de crecimiento del endotelio vascular en la angiog{\'e}nesis",
abstract = "Vascular endothelial growth factor (VEGF) is an important angiogenic factor. VEGF family includes VEGF-A, VEGF-B, VEGF-C, VEGF-D, VEGF-E and placental growth factor (PIGF) which by different interactions with three tyrosine kinase receptors, including VEGFR-1/Flt-1. VEGFR-2/Flk-1 and VEGFR-3/Flt-4, and two non protein tyrosine kinase receptors, including neuropilin-1 and -2, are responsible for endothelial cells proliferation, migration and expression of chemokines, cytokines and matrix metalloproteinases. VEGF, expressed in response to cytokines, growth factors, hormones, extracellular proteases, and hypoxia, has been detected in different tissues, such as brain, liver, spleen, kidney and skin, where it is produced by several cytotypes, including endothelial cells, fibroblasts, keratinocytes, macrophages, mast cells and tumor cells. VEGF is involved in several physiological and pathological conditions, including embryo development, vasculogenesis and early hematopoiesis, ovulation, wound repair, psoriasis, endometriosis, arteriosclerosis, diabetic retinophathy, neovascular age-related macular degeneration of the eye, chronic inflammatory diseases, and tumors. Since angiogenesis is a key event in tumor growth, invasion and metastasis. VEGF has been proposed as a therapeutic target in several tumor types, such as breast cancer, renal cell cancer, colorectal cancer and non small cells lung cancer. Furthermore, VEGF may be an interesting therapeutic agent in ischemic heart and peripheral diseases. Copyrigth",
keywords = "Angiogenesis, Antiangiogenesis, Endothelial cell, Tumor growth",
author = "Nicola Maruotti and Domenico Ribatti",
year = "2008",
month = "9",
language = "Spagnolo",
volume = "16",
pages = "383--386",
journal = "Salud (i) Ciencia",
issn = "1667-8982",
publisher = "Sociedad Iberoamericana de Informacion Cientifica",
number = "4",

}

TY - JOUR

T1 - Importancia del factor de crecimiento del endotelio vascular en la angiogénesis

AU - Maruotti, Nicola

AU - Ribatti, Domenico

PY - 2008/9

Y1 - 2008/9

N2 - Vascular endothelial growth factor (VEGF) is an important angiogenic factor. VEGF family includes VEGF-A, VEGF-B, VEGF-C, VEGF-D, VEGF-E and placental growth factor (PIGF) which by different interactions with three tyrosine kinase receptors, including VEGFR-1/Flt-1. VEGFR-2/Flk-1 and VEGFR-3/Flt-4, and two non protein tyrosine kinase receptors, including neuropilin-1 and -2, are responsible for endothelial cells proliferation, migration and expression of chemokines, cytokines and matrix metalloproteinases. VEGF, expressed in response to cytokines, growth factors, hormones, extracellular proteases, and hypoxia, has been detected in different tissues, such as brain, liver, spleen, kidney and skin, where it is produced by several cytotypes, including endothelial cells, fibroblasts, keratinocytes, macrophages, mast cells and tumor cells. VEGF is involved in several physiological and pathological conditions, including embryo development, vasculogenesis and early hematopoiesis, ovulation, wound repair, psoriasis, endometriosis, arteriosclerosis, diabetic retinophathy, neovascular age-related macular degeneration of the eye, chronic inflammatory diseases, and tumors. Since angiogenesis is a key event in tumor growth, invasion and metastasis. VEGF has been proposed as a therapeutic target in several tumor types, such as breast cancer, renal cell cancer, colorectal cancer and non small cells lung cancer. Furthermore, VEGF may be an interesting therapeutic agent in ischemic heart and peripheral diseases. Copyrigth

AB - Vascular endothelial growth factor (VEGF) is an important angiogenic factor. VEGF family includes VEGF-A, VEGF-B, VEGF-C, VEGF-D, VEGF-E and placental growth factor (PIGF) which by different interactions with three tyrosine kinase receptors, including VEGFR-1/Flt-1. VEGFR-2/Flk-1 and VEGFR-3/Flt-4, and two non protein tyrosine kinase receptors, including neuropilin-1 and -2, are responsible for endothelial cells proliferation, migration and expression of chemokines, cytokines and matrix metalloproteinases. VEGF, expressed in response to cytokines, growth factors, hormones, extracellular proteases, and hypoxia, has been detected in different tissues, such as brain, liver, spleen, kidney and skin, where it is produced by several cytotypes, including endothelial cells, fibroblasts, keratinocytes, macrophages, mast cells and tumor cells. VEGF is involved in several physiological and pathological conditions, including embryo development, vasculogenesis and early hematopoiesis, ovulation, wound repair, psoriasis, endometriosis, arteriosclerosis, diabetic retinophathy, neovascular age-related macular degeneration of the eye, chronic inflammatory diseases, and tumors. Since angiogenesis is a key event in tumor growth, invasion and metastasis. VEGF has been proposed as a therapeutic target in several tumor types, such as breast cancer, renal cell cancer, colorectal cancer and non small cells lung cancer. Furthermore, VEGF may be an interesting therapeutic agent in ischemic heart and peripheral diseases. Copyrigth

KW - Angiogenesis

KW - Antiangiogenesis

KW - Endothelial cell

KW - Tumor growth

UR - http://www.scopus.com/inward/record.url?scp=56849106470&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=56849106470&partnerID=8YFLogxK

M3 - Articolo

AN - SCOPUS:56849106470

VL - 16

SP - 383

EP - 386

JO - Salud (i) Ciencia

JF - Salud (i) Ciencia

SN - 1667-8982

IS - 4

ER -